Catalyst Wire Dossier Catalyst Wire Dossier

Insulin 320

· Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Insulin 320, covering 2016-08-01 to 2016-08-01. Get the full timeline:

Most recent: Clinical Trial Update: A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Insulin 320 in Healthy Subjects [Phase 1]

See pricing